TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that internationally renowned physician-scientist Jerald Radich, M.D., a pioneer in the fields of leukemia research and molecular genetics, has joined HTG’s Therapeutics Scientific Advisory Board. Dr. Radich adds to the company’s […]
SAN DIEGO — Bionano Genomics, Inc. (BNGO), provider of optical genome mapping (OGM) solutions on the Saphyr® system and the leading software for genomic data visualization, interpretation and reporting, today announced the launch of version 6.1 of BioDiscovery’s NxClinical software with expanded capabilities for next-generation sequencing (NGS) data in genetic diseases and cancer. NxClinical is an […]
Oxford expansion supports U.K. customers with fast turnaround time on research products, and technical support OXFORD, England —GenScript Biotech Corp., a global biotechnology group, announced today that it has expanded operations in the United Kingdom with new offices and a fully functional logistics center in Oxford. The facility supports U.K. customers with fast delivery of […]
Männedorf, Switzerland – Tecan Group Ltd. (SIX Swiss Exchange: TECN) announced today that its Board of Directors will propose the election of Myra Eskes as a new independent member of the Board at Tecan’s next Annual General Meeting on April 12, 2022. Tecan, a pioneer and global leader in laboratory automation for life sciences and diagnostics, expanded into the medical devices sector with the acquisition of Paramit Corporation in August 2021. With more than […]
NEXT-GENERATION SEQUENCING PLATFORM WILL PROVIDE UP TO THREE TIMES MORE DATA OUTPUT PER HOUR THAN OTHER BENCHTOP INSTRUMENTS, WHILE OFFERING FLEXIBLE RUN CAPACITY – LA JOLLA, Calif. — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the commercial launch of […]
Collaboration aims to combine Twist’s proprietary synthetic antibody libraries and sophisticated bioinformatics expertise with Sosei Heptares’ world-leading StaR® (stabilized receptor) platform to generate novel antibody leads to disease-relevant GPCR targets SOUTH SAN FRANCISCO, Calif.–Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, […]
Research Triangle Park, NC – – EpiCypher, Inc. announces the co-exclusive licensing of CUT&RUN / CUT&Tag technology from Fred Hutchinson Cancer Research Center. This agreement strengthens EpiCypher’s intellectual property portfolio that includes CUT&RUN / CUT&Tag workflows for both Research Use Only (RUO) and diagnostics applications. EpiCypher is now firmly established as the leading commercial developer […]
SHENZHEN — MGI Tech Co., Ltd. (“MGI”), a global life science leader and innovator, is playing an instrumental role in the global battle against the omicron variant of COVID-19 with its DNBSEQ™ and ATOPlex technologies. As a responsible global company, and as omicron begins to rapidly spread around the world, MGI’s innovative equipment has been […]
– The financing will support development of a commercial instrument system based on the company’s proprietary and disruptive MAGNA™ technology. – MAGNA™ is set to unlock the field of dynamic genomics. – Funds raised from a global investor syndicate led by Lansdowne Partners and Bpifrance and supported by funds bringing additional experience in the life […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that synthetic RNA positive controls are now available for the SARS-CoV-2 Omicron (B.1.1.529/BA.1) variants first identified in South Africa. Since the initial discovery, the variant has […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
